Keywords: alizyme, gets, ok, obesity, drug, trials, uk

Alizyme gets OK for obesity drug trials in UK

Article | 24 June 2002

Print This

UK-based biopharmaceutical company Alizyme has been granted permission by the UK Medicines Control Agency to undertake a Phase IIb trial ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in